Trial Details
COMPLETEDBasic Information
| Clinical ID | c3212 |
|---|---|
| Identifier | NCT02387359 |
| Trial Title | The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome Characterized by Constipation |
| Interventions | DRUG: Plecanatide|DRUG: Placebo |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Athens |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-12 |
|---|---|
| Primary Completion Date | 2016-12 |
| Completion Date | 2017-02 |